Company Filing History:
Years Active: 2025
Title: Samir Moussa: Innovator in Microbial Dysbiosis Management
Introduction
Samir Moussa is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of microbiology, particularly in managing microbial dysbiosis. His innovative approach utilizes temocillin to address various intestinal disorders.
Latest Patents
Samir Moussa holds a patent for "Managing microbial dysbiosis with temocillin." This patent outlines methods for using temocillin to control microbial dysbiosis, particularly arising from enterobacteriaceae overgrowth, such as adherent invasive E. coli (AIEC). The methods described in the patent aim to treat intestinal disorders and alleviate symptoms caused by microbial dysbiosis.
Career Highlights
Samir Moussa is currently associated with Entasis Therapeutics, Inc., where he continues to advance his research and innovations. His work focuses on developing effective treatments for microbial-related health issues.
Collaborations
Some of his notable coworkers include Ramkumar Iyer and Adam Shapiro, who contribute to the collaborative efforts at Entasis Therapeutics, Inc.
Conclusion
Samir Moussa's work in managing microbial dysbiosis through innovative methods showcases his dedication to improving health outcomes. His contributions to the field are significant and continue to influence research and treatment strategies.